Abstract
A general approach to the establishment of dosing regimens for drug administration by multiple intravenous infusions is presented. The method is applicable where the elimination kinetics are first order and can be represented by a one-compartment open model. The approach utilizes serum concentration-time data obtained during any dosing interval for the calculation of the apparent distribution volume and the half-life in individual patients. These values are then used to individualize the dosing regimen where it is required to maintain serum concentrations of the drug within a desired range. Estimation of kinetic parameters for gentamicin in burn patients with normal or only slightly reduced renal function demonstrates a relatively constant distribution volume of 0.25 ± 0.086 liter/kg (mean ± sd)but a relatively variable half-life of 2.1 ± 1.3 hr. This finding supports the view that gentamicin regimens should be individualized even in patients with essentially normal renal function.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
M. C. McHenry, T. L. Gavan, R. W. Gifford, Jr., N. A. Geurkink, R. A. Van Ommen, M. A. Town, and J. G. Wagner. Gentamicin dosages for renal insufficiency.Ann. Int. Med. 74:192–197 (1971).
D. Kaye, M. E. Levison, and E. D. Labovitz. The unpredictability of serum concentrations of gentamicin: Pharmacokinetics of gentamicin in patients with normal and abnormal renal function.J. Infect. Dis. 130:150–154 (1974).
A. M. Gyselynck, A. Forrey, and R. Cutler. Pharmacokinetics of gentamicin: Distribution and plasma and renal clearance.J. Infect. Dis. Suppl. 124:S70-S76 (1971).
E. L. Goodman, J. Van Gelder, R. K. Holmes, A. R. Hull, and J. P. Sanford. Gentamicin serum levels, dose response, and nephrotoxicity. Abstracts of the 14th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1974.
J. C. Gingell and P. M. Waterworth. Dose of gentamicin in patients with normal renal function and renal impairment.Brit. Med. J. 2:19–22 (1968).
R. E. Cutler, A. M. Gyselynck, W. P. Fleet, and A. W. Forrey. Correlation of serum creatinine concentration and gentamicin half-life.J. Am. Med. Assoc. 219:1037–1041 (1972).
R. A. Chan, E. J. Benner, and P. D. Hoeprich. Gentamicin therapy in renal failure: A nomogram for dosage.Ann. Int. Med. 76:773–778 (1972).
G. E. Mawer, R. Ahmad, S. M. Dobbs, J. G. McGough, S. B. Lucus, and J. A. Tooth. Prescribing aids for gentamicin.Brit. J. Clin. Pharmacol. 1:45–50 (1974).
M. E. Lund, D. J. Blazevic, and J. M. Matsen. Rapid gentamicin bioassay using a multiple-antibiotic-resistant strain ofKlebsiella pneumoniae.Antimicrob. Agents Chemother. 4: 569–573 (1973).
H. O. Hartley. The modified Gauss-Newton method for the fitting of nonlinear regression functions by least squares.Technometrics 3:269–280 (1961).
H. O. Hartley and A. Booker. Non-linear least squares estimation.Ann. Math. Stat. 36: 638–650 (1965).
J. W. Paisley, A. L. Smith, and D. H. Smith. Gentamicin in newborn infants.Am. J. Dis. Child. 126:473–477 (1973).
G. H. McCracken, Jr.. Clinical pharmacology of gentamicin in infants 2 to 24 months of age.Am. J. Dis. Child. 124:884–887 (1972).
J. B. Scarborough.Numerical Mathematical Analysis, 6th ed., Johns Hopkins Press, Baltimore, 1966, pp. 551–552.
M. Barza, R. B. Brown, D. Shen, M. Gibaldi, and L. Weinstein. Predictability of blood levels of gentamicin in man.J. Infect. Dis. 132:165–174 (1975).
Author information
Authors and Affiliations
Additional information
NIH Grant RR-267 supported our use of the computer within the Health Computer Sciences Facility at the University of Minnesota.
Rights and permissions
About this article
Cite this article
Sawchuk, R.J., Zaske, D.E. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patients. Journal of Pharmacokinetics and Biopharmaceutics 4, 183–195 (1976). https://doi.org/10.1007/BF01086153
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01086153